Polaris Venture Management Co. V as of June 30, 2017
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 8 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Selecta Biosciences (RNAC) | 39.5 | $38M | 1.9M | 19.86 | |
| Cerulean Pharma | 15.1 | $15M | 3.3M | 4.44 | |
| Genocea Biosciences | 10.6 | $10M | 2.0M | 5.22 | |
| Pulmatrix | 8.9 | $8.6M | 3.6M | 2.38 | |
| Fate Therapeutics (FATE) | 8.3 | $8.0M | 2.5M | 3.24 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 6.4 | $6.2M | 1.8M | 3.40 | |
| T2 Biosystems | 6.2 | $6.0M | 1.9M | 3.21 | |
| Trevena | 4.9 | $4.7M | 2.1M | 2.30 |
